Nuvectis Pharma (NVCT) grants director Juan Sanchez 35,000 restricted shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Sanchez Juan reported acquisition or exercise transactions in this Form 4 filing.
Nuvectis Pharma director Juan Sanchez received a grant of 35,000 shares of restricted common stock at no cost. The award will vest in equal annual installments over three years, starting on the first anniversary of the grant date, as long as he continues serving on the Board of Directors.
After this grant, Sanchez holds 113,380 common shares directly and 415 shares indirectly as custodian for his son. The filing also notes that his current holdings include 230 restricted shares that had been inadvertently omitted from his earlier Form 3.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Sanchez Juan
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 35,000 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 113,380 shares (Direct, null);
Common Stock — 415 shares (Indirect, As custodian for son)
Footnotes (1)
- The 35,000 shares of restricted common stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Dr. Sanchez's continued service on the Company's Board of Directors on such dates. Includes 230 shares of restricted common stock that were inadvertently omitted from the initial holdings on Dr Sanchez's Form 3, filed on October 31, 2025.
Key Figures
Restricted stock grant: 35,000 shares
Grant price: $0.0000 per share
Direct holdings after grant: 113,380 shares
+3 more
6 metrics
Restricted stock grant
35,000 shares
Restricted common stock awarded to director Juan Sanchez
Grant price
$0.0000 per share
Reported price for restricted stock grant
Direct holdings after grant
113,380 shares
Common stock directly owned by Juan Sanchez after transaction
Indirect holdings
415 shares
Common stock held as custodian for son
Previously omitted restricted shares
230 shares
Restricted common stock omitted from initial Form 3, now included
Vesting period
3 years
Equal annual installments beginning on first anniversary of grant
Key Terms
restricted common stock, vest, Board of Directors, Form 3, +1 more
5 terms
restricted common stock financial
"The 35,000 shares of restricted common stock will vest in equal annual installments"
Restricted common stock is company shares that carry limits on selling or transferring for a set period or until certain conditions are met, like time-based vesting or regulatory clearance. Think of them as shares in a locked box that gradually open; they can become freely tradable later but initially reduce the number of shares available on the market. Investors watch restricted stock because its eventual release can change a company’s share supply, affect stock price, and influence control and dilution.
vest financial
"will vest in equal annual installments over three years beginning on the first anniversary"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Board of Directors financial
"subject to Dr. Sanchez's continued service on the Company's Board of Directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
Form 3 regulatory
"that were inadvertently omitted from the initial holdings on Dr Sanchez's Form 3"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
indirect ownership financial
"direct_or_indirect": "I", "nature_of_ownership": "As custodian for son""
FAQ
What did Nuvectis Pharma (NVCT) director Juan Sanchez report in this Form 4?
Juan Sanchez reported receiving 35,000 shares of restricted common stock as a grant. The award was given at no cost and increases his direct holdings to 113,380 shares, plus 415 shares held indirectly as custodian for his son.
What clarification does the NVCT Form 4 give about Juan Sanchez’s earlier Form 3?
The Form 4 notes that 230 restricted common shares were inadvertently omitted from Sanchez’s initial Form 3. Those 230 shares are now included in his reported current holdings, providing a more accurate picture of his ownership position.